Skip to main content
. 2022 Mar 9;1(2):51–60. doi: 10.1016/j.jacig.2022.01.004

Table III.

Prevalence of eczema, labeled ever and doctor-confirmed eczema and severity in children and adults

Symptoms 6-7 y (N = 20,084)
13-14 y (N = 25,887)
Adults (N = 81,296)
M (N = 10,441) F (N = 9,643) P value Total M (N = 12,671) F (N = 13,216) P value Total M (N = 40,468) F (N = 40,815) P value Total
Prevalence of symptoms ever 605 (5.79) 403 (4.18) <.0001 1,008 (5.01) 1,309 (10.33) 1,080 (8.17) <.0001 2,469 (9.50) NA NA NA NA
Prevalence of current symptoms 298 (2.85) 202 (2.09) <.0001 498 (2.47) 532 (4.17) 376 (2.83) <.0001 902 (3.48) NA NA NA NA
Labeled disease condition 558 (5.34) 563 (5.84) .038 1,121 (5.60) 1,390 (10.97) 996 (7.54) <.0001 2,386 (9.20) 4,121 (10.20) 3,963 (9.70) .191 8,084 (9.90)
Diagnosis confirmed by doctor 351 (3.36) 324 (3.36) .01 675 (3.40) 570 (4.50) 394 (2.98) <.0001 964 (3.70) 2,375 (5.90) 2,381 (5.80) .025 4,757 (5.90)
Moderately severe eczema 131 (1.25) 91 (0.94) .035 222 (1.10) 553 (4.36) 449 (3.40) .0001 1,002 (3.90) NA NA NA NA
Severe eczema 47 (0.45) 20 (0.21) .003 67 (0.30) 366 (2.89) 280 (2.12) .0001 646 (2.50) NA NA NA NA

NA, Questions not included in adult questionnaire.

Values are n (%).

Eczema, Itchy rash at any time in the past 12 mo + rash on flexural surfaces.

Moderately severe eczema, condition interfering with daily activities a moderate amount.

Severe eczema, condition interfering with daily activities a lot.

High morbidity due to eczema, rash not cleared at any time in the past 12 mo.

Sex is not defined for 13 adults.